Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2245 (112th)

Preserving Access to Life-Saving Medications Act of 2011

referredUnited States· United States Congress· EN

Introduced

21 June 2011

Last action

22 June 2011 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. DeGette, Diana [D-CO-1], Rep. Rooney, Thomas J. [R-FL-17], Rep. Connolly, Gerald E. [D-VA-11], Rep. Latham, Tom [R-IA-3], Rep. Cummings, Elijah E. [D-MD-7], Rep. Slaughter, Louise McIntosh [D-NY-25], Rep. Jones, Walter B., Jr. [R-NC-3], Rep. Ellison, Keith [D-MN-5], Rep. Lewis, John [D-GA-5], Rep. Butterfield, G. K. [D-NC-1], Rep. Quigley, Mike [D-IL-5], Rep. McGovern, James P. [D-MA-2], Rep. Johnson, Henry C. "Hank" [D-GA-4], Rep. Lowey, Nita M. [D-NY-17], Rep. Langevin, James R. [D-RI-2], Rep. Moran, James P. [D-VA-8], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Napolitano, Grace F. [D-CA-32], Rep. Eshoo, Anna G. [D-CA-18], Rep. DeFazio, Peter A. [D-OR-4], Rep. Pingree, Chellie [D-ME-1], Rep. Tierney, John F. [D-MA-6], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Michaud, Michael H. [D-ME-2], Rep. Cicilline, David N. [D-RI-1], Rep. McCollum, Betty [D-MN-4], Rep. Nadler, Jerrold [D-NY-12], Rep. Lipinski, Daniel [D-IL-3], Rep. Hinchey, Maurice D. [D-NY-22], Rep. Rothman, Steven R. [D-NJ-9], Rep. Loebsack, David [D-IA-2], Rep. Woolsey, Lynn C. [D-CA-6], Rep. Roby, Martha [R-AL-2], Rep. Platts, Todd Russell [R-PA-19], Rep. Ross, Dennis A. [R-FL-15], Rep. Young, C. W. Bill [R-FL-13], Rep. Womack, Steve [R-AR-3], Rep. West, Allen B. [R-FL-22], Rep. Diaz-Balart, Mario [R-FL-26], Rep. Carney, John C., Jr. [D-DE-At Large], Rep. Yarmuth, John A. [D-KY-3], Rep. Maloney, Carolyn B. [D-NY-12], Rep. Boswell, Leonard L. [D-IA-3], Rep. Israel, Steve [D-NY-3], Rep. Grijalva, Raúl M. [D-AZ-7], Del. Bordallo, Madeleine Z. [D-GU-At Large], Rep. King, Peter T. [R-NY-2], Rep. Young, Don [R-AK-At Large]

Subjects

Healthcare

Source updated

14 August 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Preserving Access to Life-Saving Medications Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to require the manufacturer of a prescription drug marketed in interstate commerce to notify the Secretary of Health and Human Services (HHS) of a discontinuance or interruption in the manufacture of such drug. Requires the notification to be submitted six months prior to the date of a discontinuance or interruption, if possible. Allows the reduction of the notification period if the manufacturer certifies to the Secretary that good cause exists for the reduction. Authorizes the Secretary to reduce the notification period based on the type of discontinuance or interruption at issue or any other factor. Treats any information provided to the Secretary under this Act as a trade secret or confidential information. Establishes civil monetary penalties for violations. Requires the Secretary to publish on the website of the Food and Drug Administration (FDA) and distribute to the appropriate health care providers and patient organizations information on discontinuances, interruptions, and drug shortages. Requires the Secretary to notify a manufacturer of: (1) any determination by the Secretary that a drug may be vulnerable to a drug shortage, and (2) the Secretary's duty to collaborate to improve continuity of supply. Prohibits the Secretary from requiring a manufacturer to: (1) manufacture a drug in the event of a discontinuance or interruption, or (2) delay or alter a discontinuance or interruption. Declares that no provision of federal law shall be construed to prohibit a manufacturer from, or penalize a manufacturer for, allocating distribution of its products in order to manage an actual or potential drug shortage. Requires the Comptroller General to examine issues related to drug shortages.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 21 June 2011

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 21 June 2011

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 21 June 2011

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 22 June 2011

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 21 June 2011

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 21 June 2011

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 21 June 2011

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 98 sponsors and actors.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.